Trial Outcomes & Findings for Micro-osteoperforations and Tooth Movement (NCT NCT02473471)

NCT ID: NCT02473471

Last Updated: 2017-11-28

Results Overview

The baseline 3D digital model was superimposed to 3D digital models of the 1st month to determine the anterioposterior displacement of canines.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

35 participants

Primary outcome timeframe

Baseline to 1st month

Results posted on

2017-11-28

Participant Flow

Participants recruited from a postgraduate clinic at Jordanian University of Science and Technology, in Irbid city, Jordan between Aug 2015 and Jan 2016.

Participant milestones

Participant milestones
Measure
All Study Participants
Split-mouth design study in which the intervention (MOP Side) was randomly assigned to either right or the left side in the maxillary arch where other side serves as a control. Randomization was accomplished with block randomization with a permuted block size of 2 with 1:1 allocation ratio to either right or left with allocations concealed in opaque, sealed envelopes. Blinding was applicable at data collection and analysis stage.
Overall Study
STARTED
35
Overall Study
Received Allocated Intervention
33
Overall Study
Randomized Not Treated
2
Overall Study
COMPLETED
32
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
All Study Participants
Split-mouth design study in which the intervention (MOP Side) was randomly assigned to either right or the left side in the maxillary arch where other side serves as a control. Randomization was accomplished with block randomization with a permuted block size of 2 with 1:1 allocation ratio to either right or left with allocations concealed in opaque, sealed envelopes. Blinding was applicable at data collection and analysis stage.
Overall Study
poor oral hygiene
2
Overall Study
Lost to Follow-up
1

Baseline Characteristics

Micro-osteoperforations and Tooth Movement

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Study Participants
n=35 Participants
Includes groups randomized to receive MOP intervention on one side while the other side serve as control side.
Age, Continuous
19.26 years
STANDARD_DEVIATION 2.48 • n=5 Participants
Sex: Female, Male
Female
25 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
Region of Enrollment
Jordan
35 participants
n=5 Participants
Sella-Nasion to A Point Angle (SNA)
81.9 Degree
STANDARD_DEVIATION 4.07 • n=5 Participants
Sella-Nasion to B Point Angle (SNB)
76.5 Degree
STANDARD_DEVIATION 3.85 • n=5 Participants
A point to B Point Angle (ANB)
5.5 Degree
STANDARD_DEVIATION 2.69 • n=5 Participants
Maxillary mandibular plane angle
28.9 Degree
STANDARD_DEVIATION 4.27 • n=5 Participants
Lower anterior facial height(LAFH)
55.67 mm
STANDARD_DEVIATION 1.81 • n=5 Participants
Upper incisor inclination
119.94 Degree
STANDARD_DEVIATION 7.53 • n=5 Participants

PRIMARY outcome

Timeframe: Baseline to 1st month

Population: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. Three impressions were missing at first month due to alginate distortion.

The baseline 3D digital model was superimposed to 3D digital models of the 1st month to determine the anterioposterior displacement of canines.

Outcome measures

Outcome measures
Measure
MOP Side
n=29 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=29 Participants
Non intervention side
3D Digital Model Measurements of Canine Rate of Tooth Movement
0.65 mm
Standard Deviation 0.26
0.67 mm
Standard Deviation 0.34

PRIMARY outcome

Timeframe: Baseline to 2nd month

Population: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. only one impression was lost to be taken by a clinician at two months period.

The baseline 3D digital model was superimposed to 3D digital models of 2nd month to determine the anterioposterior displacement of canines.

Outcome measures

Outcome measures
Measure
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=31 Participants
Non intervention side
3D Digital Model Measurements of Canine Rate of Tooth Movement
1.36 mm
Standard Deviation 0.49
1.28 mm
Standard Deviation 0.50

PRIMARY outcome

Timeframe: Baseline to 3rd month

Population: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. Three impressions were missing at first month due to alginate distortion, and only one impression was lost to be taken by a clinician at two months.

The baseline 3D digital model was superimposed to 3D digital models of 3rd month to determine the anterioposterior displacement of canines.

Outcome measures

Outcome measures
Measure
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=32 Participants
Non intervention side
3D Digital Model Measurements of Canine Rate of Tooth Movement
1.93 mm
Standard Deviation 0.74
1.88 mm
Standard Deviation 0.67

PRIMARY outcome

Timeframe: Baseline to 1st month

Population: 32 subjects were analyzed to receive MOP to either right or left sides. Only one patient was lost to follow up at the first month time point.

Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.

Outcome measures

Outcome measures
Measure
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=31 Participants
Non intervention side
Intra Oral Measurements of Canine Rate of Tooth Movement
1.23 mm
Standard Deviation 0.45
1.17 mm
Standard Deviation 0.42

PRIMARY outcome

Timeframe: Baseline to 2nd month

Population: 32 subjects were analyzed to receive MOP to either right or left sides.

Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.

Outcome measures

Outcome measures
Measure
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=32 Participants
Non intervention side
Intra Oral Measurements of Canine Rate of Tooth Movement
2.27 mm
Standard Deviation 0.72
2.24 mm
Standard Deviation 0.63

PRIMARY outcome

Timeframe: Baseline to 3 month

Population: 32 subjects were analyzed who received MOP to either right or left sides.

Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.

Outcome measures

Outcome measures
Measure
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=32 Participants
Non intervention side
Intra Oral Measurements of Canine Rate of Tooth Movement
3.18 mm
Standard Deviation 1.03
3.26 mm
Standard Deviation 0.81

SECONDARY outcome

Timeframe: Baseline to 3rd month

It will be evaluated by taking periapical radiograph for canines before canine retraction and after 3 months period

Outcome measures

Outcome measures
Measure
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=31 Participants
Non intervention side
Root Resorption
Root length at baseline
19.96 mm
Standard Deviation 2.2
19.66 mm
Standard Deviation 2.5
Root Resorption
Root length at 3 months
19.35 mm
Standard Deviation 2.0
18.93 mm
Standard Deviation 2.6

SECONDARY outcome

Timeframe: within 7 days after the intervention

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.

Outcome measures

Outcome measures
Measure
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=32 Participants
Non intervention side
Pain Intensity
12 hour
2.6 units on a scale
Standard Deviation 2.79
1.6 units on a scale
Standard Deviation 2.35
Pain Intensity
Day 1
1.2 units on a scale
Standard Deviation 1.95
0.8 units on a scale
Standard Deviation 1.36
Pain Intensity
Day 3
0.8 units on a scale
Standard Deviation 1.41
0.6 units on a scale
Standard Deviation 1.29
Pain Intensity
Day 5
0.4 units on a scale
Standard Deviation 1.10
0.3 units on a scale
Standard Deviation 1.18
Pain Intensity
Day 7
0.2 units on a scale
Standard Deviation 0.71
0.3 units on a scale
Standard Deviation 1.28
Pain Intensity
Immediate
1.4 units on a scale
Standard Deviation 1.74
1.0 units on a scale
Standard Deviation 1.99
Pain Intensity
1 hour
2.4 units on a scale
Standard Deviation 2.15
1.5 units on a scale
Standard Deviation 2.23

SECONDARY outcome

Timeframe: within 7 days after the intervention

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.

Outcome measures

Outcome measures
Measure
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=32 Participants
Non intervention side
Pain Interference /Pain During Eating?
Day 1
3.10 units on a scale
Standard Deviation 2.61
2.00 units on a scale
Standard Deviation 2.54
Pain Interference /Pain During Eating?
Day 3
1.03 units on a scale
Standard Deviation 1.58
0.65 units on a scale
Standard Deviation 1.23
Pain Interference /Pain During Eating?
Day 5
0.29 units on a scale
Standard Deviation 0.74
0.19 units on a scale
Standard Deviation 0.60
Pain Interference /Pain During Eating?
Day 7
0.13 units on a scale
Standard Deviation 0.56
0.10 units on a scale
Standard Deviation 0.54

SECONDARY outcome

Timeframe: within 7 days after the intervention

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.

Outcome measures

Outcome measures
Measure
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=31 Participants
Non intervention side
Pain Interference /Pain Interrupted Sleep
Day 1
0.58 units on a scale
Standard Deviation 1.69
0.19 units on a scale
Standard Deviation 0.91
Pain Interference /Pain Interrupted Sleep
Day 3
0.13 units on a scale
Standard Deviation 0.56
0.03 units on a scale
Standard Deviation 0.18
Pain Interference /Pain Interrupted Sleep
Day 5
0.06 units on a scale
Standard Deviation 0.36
0.00 units on a scale
Standard Deviation 0.00
Pain Interference /Pain Interrupted Sleep
Day 7
0.00 units on a scale
Standard Deviation 0.00
0.00 units on a scale
Standard Deviation 0.00

SECONDARY outcome

Timeframe: within 7 days after the intervention

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no swelling and 10 = worst swelling.

Outcome measures

Outcome measures
Measure
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=31 Participants
Non intervention side
Pain Interference /Swelling of the Surgical Side
Day 1
1.23 units on a scale
Standard Deviation 1.68
0.41 units on a scale
Standard Deviation 1.38
Pain Interference /Swelling of the Surgical Side
Day 3
0.48 units on a scale
Standard Deviation 1.18
0.26 units on a scale
Standard Deviation 1.26
Pain Interference /Swelling of the Surgical Side
Day 5
0.26 units on a scale
Standard Deviation 0.82
0.00 units on a scale
Standard Deviation 0.00
Pain Interference /Swelling of the Surgical Side
Day 7
0.06 units on a scale
Standard Deviation 0.25
0.00 units on a scale
Standard Deviation 0.00

SECONDARY outcome

Timeframe: within 7 days after the intervention

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no discomfort and 10 = worst discomfort.

Outcome measures

Outcome measures
Measure
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
n=31 Participants
Non intervention side
Pain Interference /Discomfort
Day 1
2.10 units on a scale
Standard Deviation 2.52
1.29 units on a scale
Standard Deviation 2.19
Pain Interference /Discomfort
Day 3
0.77 units on a scale
Standard Deviation 1.36
0.58 units on a scale
Standard Deviation 1.29
Pain Interference /Discomfort
Day 5
0.23 units on a scale
Standard Deviation 0.56
0.10 units on a scale
Standard Deviation 0.40
Pain Interference /Discomfort
Day 7
0.06 units on a scale
Standard Deviation 0.25
0.03 units on a scale
Standard Deviation 0.18

SECONDARY outcome

Timeframe: After 7 days of MOP application

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = unsatisfied and 10 = most satisfaction.

Outcome measures

Outcome measures
Measure
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
Control Side
Non intervention side
Patient Satisfaction
8.94 units on a scale
Standard Deviation 1.35

SECONDARY outcome

Timeframe: within 3 months

Population: Sufficient data were not collected from any participant

the relationship between the rate of tooth movement and Menstrual cycle

Outcome measures

Outcome data not reported

Adverse Events

MOP Side

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Side

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr.Amal Alkebsi

Jordanian University of science and Technology

Phone: 00966552358684

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place